Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
:TOI
Total Valuation
Oncology Institute has a market cap or net worth of $299.08M. The enterprise value is $416.08M.
Market Cap$299.08M
Enterprise Value$416.08M
Share Statistics
Oncology Institute has 98,381,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98,381,340
Owned by Insiders15.60%
Owned by Institutions13.89%
Financial Efficiency
Oncology Institute’s return on equity (ROE) is -18.02 and return on invested capital (ROIC) is -47.23%.
Return on Equity (ROE)-18.02
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-47.23%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee476.86K
Profits Per Employee-64.25K
Employee Count825
Asset Turnover2.28
Inventory Turnover33.81
Valuation Ratios
The current PE Ratio of Oncology Institute is ―. Oncology Institute’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.06
PB Ratio6.46
Price to Fair Value6.46
Price to FCF-0.76
Price to Operating Cash Flow-345.00
PEG Ratio0.02
Income Statement
In the last 12 months, Oncology Institute had revenue of 393.41M and earned -64.66M in profits. Earnings per share was -0.71.
Revenue393.41M
Gross Profit54.00M
Operating Income-60.12M
Pretax Income-64.66M
Net Income-64.66M
EBITDA-53.83M
Earnings Per Share (EPS)-0.71
Cash Flow
In the last 12 months, operating cash flow was -33.44M and capital expenditures -5.10M, giving a free cash flow of -38.54M billion.
Operating Cash Flow-33.44M
Free Cash Flow-38.54M
Free Cash Flow per Share-0.39
Dividends & Yields
Oncology Institute pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.55
52-Week Price Change1688.24%
50-Day Moving Average3.78
200-Day Moving Average2.79
Relative Strength Index (RSI)36.45
Average Volume (3m)2.78M
Important Dates
Oncology Institute upcoming earnings date is Mar 5, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend Date―
Financial Position
Oncology Institute as a current ratio of 2.15, with Debt / Equity ratio of -1148.08%
Current Ratio2.15
Quick Ratio1.96
Debt to Market Cap4.02
Net Debt to EBITDA-1.44
Interest Coverage Ratio-8.02
Taxes
In the past 12 months, Oncology Institute has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oncology Institute EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -3.19.
EV to Sales0.25
EV to EBITDA-1.90
EV to Free Cash Flow-3.19
EV to Operating Cash Flow-3.64
Balance Sheet
Oncology Institute has $27.66M in cash and marketable securities with $27.36M in debt, giving a net cash position of $302.00K billion.
Cash & Marketable Securities$27.66M
Total Debt$27.36M
Net Cash$302.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.25
Margins
Gross margin is 14.60%, with operating margin of -15.28%, and net profit margin of -16.44%.
Gross Margin14.60%
Operating Margin-15.28%
Pretax Margin-16.44%
Net Profit Margin-16.44%
EBITDA Margin-12.93%
EBIT Margin-14.53%
Analyst Forecast
The average price target for Oncology Institute is $6.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.50
Price Target Upside113.82% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast21.67%
EPS Growth Forecast16.74%